Annual total expenses:
$604.63M+$158.89M(+35.65%)Summary
- As of today (September 9, 2025), ARWR annual total expenses is $604.63 million, with the most recent change of +$158.89 million (+35.65%) on September 30, 2024.
- During the last 3 years, ARWR annual total expenses has risen by +$317.31 million (+110.44%).
- ARWR annual total expenses is now at all-time high.
Performance
ARWR Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$203.01M+$30.74M(+17.85%)Summary
- As of today (September 9, 2025), ARWR quarterly total expenses is $203.01 million, with the most recent change of +$30.74 million (+17.85%) on June 30, 2025.
- Over the past year, ARWR quarterly total expenses has increased by +$32.22 million (+18.86%).
- ARWR quarterly total expenses is now at all-time high.
Performance
ARWR Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ARWR Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.6% | +18.9% |
| 3 y3 years | +110.4% | +94.3% |
| 5 y5 years | +461.9% | +395.3% |
ARWR Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.4% | at high | +108.0% |
| 5 y | 5-year | at high | +461.9% | at high | +395.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ARWR Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $203.01M(+17.8%) |
| Mar 2025 | - | $172.26M(-1.9%) |
| Dec 2024 | - | $175.59M(+3.0%) |
| Sep 2024 | $604.63M(+35.6%) | $170.54M(-0.2%) |
| Jun 2024 | - | $170.79M(+36.3%) |
| Mar 2024 | - | $125.30M(-8.1%) |
| Dec 2023 | - | $136.41M(+8.5%) |
| Sep 2023 | $445.74M(+5.7%) | $125.78M(+5.9%) |
| Jun 2023 | - | $118.77M(+21.7%) |
| Mar 2023 | - | $97.59M(-6.0%) |
| Dec 2022 | - | $103.87M(-11.3%) |
| Sep 2022 | $421.74M(+46.8%) | $117.09M(+12.1%) |
| Jun 2022 | - | $104.46M(-2.8%) |
| Mar 2022 | - | $107.44M(+19.0%) |
| Dec 2021 | - | $90.31M(-11.2%) |
| Sep 2021 | $287.32M(+58.6%) | $101.66M(+34.1%) |
| Jun 2021 | - | $75.81M(+27.1%) |
| Mar 2021 | - | $59.63M(+41.9%) |
| Dec 2020 | - | $42.03M(-25.0%) |
| Sep 2020 | $181.15M(+68.3%) | $56.07M(+36.8%) |
| Jun 2020 | - | $40.99M(-5.5%) |
| Mar 2020 | - | $43.36M(+35.0%) |
| Dec 2019 | - | $32.13M(+1.7%) |
| Sep 2019 | $107.61M(+49.3%) | $31.59M(+41.3%) |
| Jun 2019 | - | $22.36M(-7.8%) |
| Mar 2019 | - | $24.25M(+7.2%) |
| Dec 2018 | - | $22.62M(+2.7%) |
| Sep 2018 | $72.08M(+5.4%) | $22.02M(+34.8%) |
| Jun 2018 | - | $16.33M(+5.1%) |
| Mar 2018 | - | $15.53M(-7.0%) |
| Dec 2017 | - | $16.71M(-14.1%) |
| Sep 2017 | $68.40M(-14.3%) | $19.45M(+30.8%) |
| Jun 2017 | - | $14.86M(-1.1%) |
| Mar 2017 | - | $15.03M(-8.7%) |
| Dec 2016 | - | $16.45M(-26.1%) |
| Sep 2016 | $79.85M(-17.1%) | $22.25M(+14.4%) |
| Jun 2016 | - | $19.46M(-6.7%) |
| Mar 2016 | - | $20.86M(+8.0%) |
| Dec 2015 | - | $19.31M(-22.1%) |
| Sep 2015 | $96.36M(+87.9%) | $24.79M(+54.3%) |
| Jun 2015 | - | $16.06M(-44.1%) |
| Mar 2015 | - | $28.73M(+26.3%) |
| Dec 2014 | - | $22.75M(+1.2%) |
| Sep 2014 | $51.28M(+117.5%) | $22.47M(+92.5%) |
| Jun 2014 | - | $11.67M(-16.5%) |
| Mar 2014 | - | $13.99M(+31.1%) |
| Dec 2013 | - | $10.67M(-22.3%) |
| Sep 2013 | $23.57M(+11.0%) | $13.74M(+124.3%) |
| Jun 2013 | - | $6.12M(-10.0%) |
| Mar 2013 | - | $6.80M(+42.5%) |
| Dec 2012 | - | $4.77M(-10.9%) |
| Sep 2012 | $21.24M | $5.36M(-33.4%) |
| Jun 2012 | - | $8.04M(+49.8%) |
| Mar 2012 | - | $5.37M(+113.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $2.51M(-9.6%) |
| Sep 2011 | $10.13M(+73.6%) | $2.78M(+58.5%) |
| Jun 2011 | - | $1.75M(+98.7%) |
| Mar 2011 | - | $881.50K(-86.3%) |
| Dec 2010 | - | $6.44M(+192.1%) |
| Sep 2010 | $5.83M(-75.0%) | $2.20M(+341.0%) |
| Jun 2010 | - | $499.50K(-75.2%) |
| Mar 2010 | - | $2.01M(-15.4%) |
| Dec 2009 | - | $2.38M(-46.3%) |
| Sep 2009 | $23.32M(-35.8%) | $4.43M(-14.2%) |
| Jun 2009 | - | $5.16M(-6.6%) |
| Mar 2009 | - | $5.52M(-36.7%) |
| Dec 2008 | - | $8.73M(+1.6%) |
| Sep 2008 | $36.31M(-7.3%) | $8.60M(+7.2%) |
| Jun 2008 | - | $8.02M(+24.9%) |
| Mar 2008 | - | $6.42M(+14.0%) |
| Dec 2007 | - | $5.64M(-30.8%) |
| Sep 2007 | $39.16M(+85.8%) | $8.15M(-37.8%) |
| Jun 2007 | - | $13.10M(+112.2%) |
| Mar 2007 | - | $6.17M(+66.0%) |
| Dec 2006 | - | $3.72M(-57.8%) |
| Sep 2006 | $21.08M(+107.0%) | $8.82M(+109.0%) |
| Jun 2006 | - | $4.22M(+33.4%) |
| Mar 2006 | - | $3.16M(-6.6%) |
| Dec 2005 | - | $3.39M(+16.7%) |
| Sep 2005 | $10.18M(+252.7%) | $2.91M(-9.5%) |
| Jun 2005 | - | $3.21M(-668.0%) |
| Mar 2005 | - | -$565.10K(-133.9%) |
| Dec 2004 | - | $1.67M(+1.8%) |
| Sep 2004 | $2.89M(+2958.4%) | $1.64M(+142.2%) |
| Jun 2004 | - | $675.40K(+284.0%) |
| Mar 2004 | - | $175.90K(-14.6%) |
| Dec 2003 | - | $205.90K(-290.5%) |
| Sep 2003 | $94.40K(-93.3%) | -$108.10K(-301.3%) |
| Jun 2003 | - | $53.70K(-49.1%) |
| Mar 2003 | - | $105.60K(+126.1%) |
| Dec 2002 | - | $46.70K(>+9900.0%) |
| Sep 2002 | $1.42M(+1127.1%) | $100.00(-99.9%) |
| Jun 2002 | - | $88.40K(+726.2%) |
| Mar 2002 | - | $10.70K(-83.4%) |
| Dec 2001 | - | $64.60K(+9128.6%) |
| Sep 2001 | $115.60K(-13.8%) | $700.00(-98.1%) |
| Jun 2001 | - | $35.90K(-30.3%) |
| Mar 2001 | - | $51.50K(+12.0%) |
| Dec 2000 | - | $46.00K(-274.2%) |
| Sep 2000 | $134.10K(+43.9%) | -$26.40K(-142.3%) |
| Jun 2000 | - | $62.40K(+2.8%) |
| Mar 2000 | - | $60.70K(-7.6%) |
| Dec 1999 | - | $65.70K(-708.3%) |
| Sep 1999 | $93.20K(+10.0%) | -$10.80K(-104.4%) |
| Jun 1999 | - | $247.30K(+930.4%) |
| Mar 1999 | - | $24.00K |
| Sep 1998 | $84.70K(-64.0%) | - |
| Sep 1997 | $235.20K | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual total expenses?
- What is the all time high annual total expenses for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of ARWR is $604.63M
What is the all time high annual total expenses for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual total expenses is $604.63M
What is Arrowhead Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, ARWR annual total expenses has changed by +$158.89M (+35.65%)
What is Arrowhead Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of ARWR is $203.01M
What is the all time high quarterly total expenses for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly total expenses is $203.01M
What is Arrowhead Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, ARWR quarterly total expenses has changed by +$32.22M (+18.86%)